Clare Ozawa, Director at Oyster Point Pharma, Inc. (OYST), bought 2,504,000 shares at $16.00 ($9.0M) on 2019-11-04, disclosed to the SEC on 2019-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,941,500 | $0 | 0.0% |
| 2 | $16.00 | 125,000 | $2.0M | 22.2% |
| 3 | $16.00 | 437,500 | $7.0M | 77.8% |
| Total | $3.59 avg | 2,504,000 | $9.0M | 100% |